Antiproliferative Activity of 2-Aroyland 2-Heteroyl-1,1,3,3-Tetracyanoprop-2-en-1-ides

The influence of previously synthesized 2-aroyl-1,1,3,3-tetracyanoprop-2-en-1-ides on the growth of conditionally normal and tumor cells was studied in continuation of a search for new anticancer drugs. Cytotoxicities of the compounds were studied with respect to human tumor cell lines from the ATCC...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical chemistry journal 2020-05, Vol.54 (2), p.142-144
Main Authors: Mar’yasov, M. A., Kayukov, Ya. S., Nasakin, O. E.
Format: Article
Language:English
Subjects:
Cancer
Chemotherapy
Medicine
Organic Chemistry
Pharmacology/Toxicology
Pharmacy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c309t-e11184ee64821f3046336ad3d5e6695e2ea495f830f4855f173e92ee0d0c92ac3
container_end_page 144
container_issue 2
container_start_page 142
container_title Pharmaceutical chemistry journal
container_volume 54
creator Mar’yasov, M. A.
Kayukov, Ya. S.
Nasakin, O. E.
description The influence of previously synthesized 2-aroyl-1,1,3,3-tetracyanoprop-2-en-1-ides on the growth of conditionally normal and tumor cells was studied in continuation of a search for new anticancer drugs. Cytotoxicities of the compounds were studied with respect to human tumor cell lines from the ATCC. All compounds were ineffective against melanoma and lung and ovary cancer cell lines and exhibited moderate activity in the other cases. The tested compounds exhibited highly selective effects because they were safe for conditionally normal skin fibroblasts.
doi_str_mv 10.1007/s11094-020-02170-6
format article
fullrecord <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracmisc_A625619238</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A625619238</galeid><sourcerecordid>A625619238</sourcerecordid><originalsourceid>FETCH-LOGICAL-c309t-e11184ee64821f3046336ad3d5e6695e2ea495f830f4855f173e92ee0d0c92ac3</originalsourceid><addsrcrecordid>eNp9kEFLAzEQhYMoWKt_wFPBa1Nnkt10c1yKWqHgpYq3EHYnJWW7W5JV2H9v6noRRIYwk-F9j-QxdouwQIDlfUQEnXEQkA4ugaszNsF8KbkGiedsAqCRYw7vl-wqxj1AwqSYsLey7f0xdI13FGzvP2lWVqn5fph1biZ4GbqhsW2dxjX1dLpxnONcziXfUh9sNdi2Sw5HLji1HLmvKV6zC2ebSDc_fcpeHx-2qzXfvDw9r8oNryTonhMiFhmRygqBTkKmpFS2lnVOSumcBNlM566Q4LIizx0uJWlBBDVUWthKTtnd6LuzDRnfuu70ooOPlSmVyBVqIYukWvyhSlXTwVddS86n_S9AjEAVuhgDOXMM_mDDYBDMKXAzBm5S4OY7cKMSJEcoJnG7o2D23Udo0_f_o74A9rl_4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Antiproliferative Activity of 2-Aroyland 2-Heteroyl-1,1,3,3-Tetracyanoprop-2-en-1-ides</title><source>Springer Nature</source><creator>Mar’yasov, M. A. ; Kayukov, Ya. S. ; Nasakin, O. E.</creator><creatorcontrib>Mar’yasov, M. A. ; Kayukov, Ya. S. ; Nasakin, O. E.</creatorcontrib><description>The influence of previously synthesized 2-aroyl-1,1,3,3-tetracyanoprop-2-en-1-ides on the growth of conditionally normal and tumor cells was studied in continuation of a search for new anticancer drugs. Cytotoxicities of the compounds were studied with respect to human tumor cell lines from the ATCC. All compounds were ineffective against melanoma and lung and ovary cancer cell lines and exhibited moderate activity in the other cases. The tested compounds exhibited highly selective effects because they were safe for conditionally normal skin fibroblasts.</description><identifier>ISSN: 0091-150X</identifier><identifier>EISSN: 1573-9031</identifier><identifier>DOI: 10.1007/s11094-020-02170-6</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Cancer ; Chemotherapy ; Medicine ; Organic Chemistry ; Pharmacology/Toxicology ; Pharmacy</subject><ispartof>Pharmaceutical chemistry journal, 2020-05, Vol.54 (2), p.142-144</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2019</rights><rights>COPYRIGHT 2020 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c309t-e11184ee64821f3046336ad3d5e6695e2ea495f830f4855f173e92ee0d0c92ac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Mar’yasov, M. A.</creatorcontrib><creatorcontrib>Kayukov, Ya. S.</creatorcontrib><creatorcontrib>Nasakin, O. E.</creatorcontrib><title>Antiproliferative Activity of 2-Aroyland 2-Heteroyl-1,1,3,3-Tetracyanoprop-2-en-1-ides</title><title>Pharmaceutical chemistry journal</title><addtitle>Pharm Chem J</addtitle><description>The influence of previously synthesized 2-aroyl-1,1,3,3-tetracyanoprop-2-en-1-ides on the growth of conditionally normal and tumor cells was studied in continuation of a search for new anticancer drugs. Cytotoxicities of the compounds were studied with respect to human tumor cell lines from the ATCC. All compounds were ineffective against melanoma and lung and ovary cancer cell lines and exhibited moderate activity in the other cases. The tested compounds exhibited highly selective effects because they were safe for conditionally normal skin fibroblasts.</description><subject>Cancer</subject><subject>Chemotherapy</subject><subject>Medicine</subject><subject>Organic Chemistry</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><issn>0091-150X</issn><issn>1573-9031</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kEFLAzEQhYMoWKt_wFPBa1Nnkt10c1yKWqHgpYq3EHYnJWW7W5JV2H9v6noRRIYwk-F9j-QxdouwQIDlfUQEnXEQkA4ugaszNsF8KbkGiedsAqCRYw7vl-wqxj1AwqSYsLey7f0xdI13FGzvP2lWVqn5fph1biZ4GbqhsW2dxjX1dLpxnONcziXfUh9sNdi2Sw5HLji1HLmvKV6zC2ebSDc_fcpeHx-2qzXfvDw9r8oNryTonhMiFhmRygqBTkKmpFS2lnVOSumcBNlM566Q4LIizx0uJWlBBDVUWthKTtnd6LuzDRnfuu70ooOPlSmVyBVqIYukWvyhSlXTwVddS86n_S9AjEAVuhgDOXMM_mDDYBDMKXAzBm5S4OY7cKMSJEcoJnG7o2D23Udo0_f_o74A9rl_4A</recordid><startdate>20200501</startdate><enddate>20200501</enddate><creator>Mar’yasov, M. A.</creator><creator>Kayukov, Ya. S.</creator><creator>Nasakin, O. E.</creator><general>Springer US</general><general>Springer</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20200501</creationdate><title>Antiproliferative Activity of 2-Aroyland 2-Heteroyl-1,1,3,3-Tetracyanoprop-2-en-1-ides</title><author>Mar’yasov, M. A. ; Kayukov, Ya. S. ; Nasakin, O. E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c309t-e11184ee64821f3046336ad3d5e6695e2ea495f830f4855f173e92ee0d0c92ac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cancer</topic><topic>Chemotherapy</topic><topic>Medicine</topic><topic>Organic Chemistry</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mar’yasov, M. A.</creatorcontrib><creatorcontrib>Kayukov, Ya. S.</creatorcontrib><creatorcontrib>Nasakin, O. E.</creatorcontrib><collection>CrossRef</collection><jtitle>Pharmaceutical chemistry journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mar’yasov, M. A.</au><au>Kayukov, Ya. S.</au><au>Nasakin, O. E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antiproliferative Activity of 2-Aroyland 2-Heteroyl-1,1,3,3-Tetracyanoprop-2-en-1-ides</atitle><jtitle>Pharmaceutical chemistry journal</jtitle><stitle>Pharm Chem J</stitle><date>2020-05-01</date><risdate>2020</risdate><volume>54</volume><issue>2</issue><spage>142</spage><epage>144</epage><pages>142-144</pages><issn>0091-150X</issn><eissn>1573-9031</eissn><abstract>The influence of previously synthesized 2-aroyl-1,1,3,3-tetracyanoprop-2-en-1-ides on the growth of conditionally normal and tumor cells was studied in continuation of a search for new anticancer drugs. Cytotoxicities of the compounds were studied with respect to human tumor cell lines from the ATCC. All compounds were ineffective against melanoma and lung and ovary cancer cell lines and exhibited moderate activity in the other cases. The tested compounds exhibited highly selective effects because they were safe for conditionally normal skin fibroblasts.</abstract><cop>New York</cop><pub>Springer US</pub><doi>10.1007/s11094-020-02170-6</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0091-150X
ispartof Pharmaceutical chemistry journal, 2020-05, Vol.54 (2), p.142-144
issn 0091-150X
1573-9031
language eng
recordid cdi_gale_infotracmisc_A625619238
source Springer Nature
subjects Cancer
Chemotherapy
Medicine
Organic Chemistry
Pharmacology/Toxicology
Pharmacy
title Antiproliferative Activity of 2-Aroyland 2-Heteroyl-1,1,3,3-Tetracyanoprop-2-en-1-ides
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T11%3A05%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antiproliferative%20Activity%20of%202-Aroyland%202-Heteroyl-1,1,3,3-Tetracyanoprop-2-en-1-ides&rft.jtitle=Pharmaceutical%20chemistry%20journal&rft.au=Mar%E2%80%99yasov,%20M.%20A.&rft.date=2020-05-01&rft.volume=54&rft.issue=2&rft.spage=142&rft.epage=144&rft.pages=142-144&rft.issn=0091-150X&rft.eissn=1573-9031&rft_id=info:doi/10.1007/s11094-020-02170-6&rft_dat=%3Cgale_cross%3EA625619238%3C/gale_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c309t-e11184ee64821f3046336ad3d5e6695e2ea495f830f4855f173e92ee0d0c92ac3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A625619238&rfr_iscdi=true